Geneviève Rousseau

Title: Geneviève Rousseau: Innovator in Biotechnology

Introduction

Geneviève Rousseau is a prominent inventor based in Québec, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of gene editing and regulation. With a total of 2 patents, Rousseau's work has the potential to impact various agricultural and biotechnological applications.

Latest Patents

Rousseau's latest patents include "Anti-CRISPR polynucleotides and polypeptides and methods of use" and "Anti-CRISPR genes and proteins and methods of use." The first patent provides methods and compositions for utilizing anti-CRISPR (ACR) proteins in plants. This includes the modulation of Cas endonuclease activity, improvement of the frequency of homologous recombination, and control of Cas endonuclease activity during various cell cycles. It also addresses spatial and temporal regulation of Cas endonuclease activity in plants, usage in gene activation or repression, and reduction of off-target polynucleotide cleavage. The second patent relates to anti-CRISPR genes and proteins, detailing their uses in various biotechnology applications.

Career Highlights

Throughout his career, Rousseau has worked with notable organizations such as DuPont Nutrition Biosciences Aps and Université Laval in Canada. His work has been instrumental in advancing the understanding and application of CRISPR technology in agricultural biotechnology.

Collaborations

Rousseau has collaborated with esteemed colleagues, including Christophe Fremaux and Philippe Horvath. These partnerships have further enriched his research and development efforts in the field.

Conclusion

Geneviève Rousseau's innovative work in biotechnology, particularly in the realm of anti-CRISPR technologies, showcases his commitment to advancing scientific knowledge and applications. His contributions are poised to make a lasting impact on the industry.